Risk factors promoting hypertensive crises: Evidence from a longitudinal study

American Journal of Hypertension

Volumn 23, Issue 7, 2010, Pages 775-780

  Saguner, Ardan M ^a   Dür, Stefan ^a   Perrig, Martin ^a   Schiemann, Uwe ^a   Stuck, Andreas E ^a   Bürgi, Ulrich ^a   Erne, Paul ^b   Schoenenberger, Andreas W ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b Luzerner Kantonsspital ^*  (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Ambulatory; Blood pressure; Blood pressure monitoring; Hypertension; Hypertensive crisis; Medication adherence

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSIVE CRISIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SOMATOFORM DISORDER; SWITZERLAND; SYSTOLIC BLOOD PRESSURE; AGED; HYPERTENSION, MALIGNANT; MEDICATION COMPLIANCE; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, MALIGNANT; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77953812443     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.71     Document Type: Article

References (32)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
2. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 1996; 27:144-147.
3. Wu PH, Yang CY, Yao ZL, Lin WZ, Wu LW, Chang CC. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan. Am J Hypertens 2010; 23:155-160.
4. Martin JF, Higashiama E, Garcia E, Luizon MR, Cipullo J P. Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol 2004; 83: 131-6; 125.
5. Tisdale JE, Huang MB, Borzak S. Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract 2004; 21:420-424.
6. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 1992; 327:776-781.
7. Sesoko S, Akema N, Matsukawa T, Kaneko Y. Predisposing factors for the development of malignant essential hypertension. Arch Intern Med 1987; 147:1721-1724.
8. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
9. Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004; 22:1849-1855.
10. Schoenenberger AW, Erne P, Ammann S, Perrig M, Bürgi U, Stuck AE. Prediction of hypertensive crisis based on average, variability and approximate entropy of 24-h ambulatory blood pressure monitoring. J Hum Hypertens 2008; 22:32-37.
11. Peytremann-Bridevaux I, Santos-Eggimann B. Health correlates of overweight and obesity in adults aged 50 years and over: results from the Survey of Health, Ageing and Retirement in Europe (SHARE). Obesity and health in Europeans aged > or = 50 years. Swiss Med Wkly 2008; 138:261-266.
12. Schoenenberger AW, Schoenenberger-Berzins R, Suter PM, Zuber M, Erne P. Effect of moderate weight reduction on resting and exercise blood pressure in overweight subjects. J Hum Hypertens 2007; 21:683-685.
13. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-1197.
14. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001; 38:1112-1117.
15. Hermida RC, Chayán L, Ayala DE, Mojón A, Domínguez MJ, Fontao MJ, Soler R, Alonso I, Fernández JR. Association of metabolic syndrome and blood pressure nondipping profile in untreated hypertension. Am J Hypertens 2009; 22:307-313.
16. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest 2000; 118:214-227.
17. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
18. Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SS. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study. Drugs Aging 2008; 25:885-892.
19. rd, Riehle JF, Walters CA, Lackland DT, Merali C, Sealey JE, Laragh JH. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens 2009; 22:792-801.
20. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, Schwartz JS. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005; 165:1147-1152.
21. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:617-627. (Pubitemid 40973437)
22. Hiller W, Rief W, Brähler E. Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 2006; 41:704-712.
23. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998; 49:196-201.
24. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10:3621-3637.
25. Erkens JA, Panneman MM, Klungel OH, van den Boom G, Prescott MF, Herings RM. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf 2005; 14:795-803.
26. Schoenenberger AW, Erne P, Ammann S, Gillmann G, Kobza R, Stuck AE. Prediction of arrhythmic events after myocardial infarction based on signal-averaged electrocardiogram and ejection fraction. Pacing Clin Electrophysiol 2008; 31:221-228.
27. Schoenenberger AW, Kobza R, Jamshidi P, Zuber M, Abbate A, Stuck AE, Pfisterer M, Erne P. Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]). Am J Cardiol 2009; 104:158-163.
28. Frishman WH. Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol Rev 2007; 15:257-263.
29. Wetzels GE, Nelemans PJ, Schouten JS, van Wijk BL, Prins MH. All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions-an observational study. BMC Health Serv Res 2006; 6:8.
30. Krüth P, Wehling M. Pharmacogenomics. What is relevant for the internal medicine specialist? Internist (Berl) 2003; 44:1524-1530.
31. Sunder-Plassmann G, Kittler H, Eberle C, Hirschl MM, Woisetschläger C, Derhaschnig U, Laggner AN, Hörl WH, Födinger M. Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. Crit Care Med 2002; 30:2236-2241.
32. van Rijn-Bikker PC, Mairuhu G, van Montfrans GA, Sijbrands EJ, Zwinderman AH, Guchelaar HJ, Koopmans R P. Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial population. Am J Hypertens 2009; 22:1295-1302.